Kepler Trust Intelligence provides research and information for professional and private investors. In order to ensure that we provide you with the right kind of content, and to ensure that the content we provide is compliant, you need to tell us what type of investor you are.Continue
IBT has had a change of management - but no change of strategy…
To achieve long-term capital growth by investing in biotechnology and other life-science companies.
SV Life Sciences Managers LLP
Ailsa Craig, Marek Poszepczynski, Kate Bingham & Houman Ashrafian
Association of Investment Companies (AIC) Sector
Biotechnology & Healthcare
12 Month Yield
Dividend Distribution Frequency
Latest Market Capitalisation
Latest Net Gearing (Cum Fair)
Latest Ongoing Charge Ex Perf Fee
(Discount)/ Premium (Cum Fair)
Daily Closing Price
Disclosure – Non-Independent Marketing Communication
This is a non-independent marketing communication commissioned by International Biotechnology. The report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on the dealing ahead of the dissemination of investment research.